PharmswellBio Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
164,874.40
1,617,020.00
9,198,911.20
4,144,514.90
346,444.50
Depreciation, Depletion & Amortization
113,218.10
150,074.60
148,994.60
174,580.00
164,702.80
Other Funds
40,000.00
45,800.00
-
-
-
Funds from Operations
407,849.30
1,646,836.60
6,228,818.70
2,826,946.60
574,436.30
Changes in Working Capital
1,760,788.10
612,066.20
2,847,913.00
502,164.50
3,836,773.00
Net Operating Cash Flow
2,168,637.40
2,258,902.80
3,380,905.70
2,324,782.10
3,262,336.70
Capital Expenditures
413,290.90
436,579.60
40,358.10
245,666.20
20,449.10
Sale of Fixed Assets & Businesses
1,665,906.60
6,543,775.10
12,090.90
30,363.60
11,400.00
Purchase/Sale of Investments
91,600.00
3,782,746.50
508,731.20
2,730,000.00
160,645.30
Net Investing Cash Flow
1,698,204.80
2,307,349.00
4,610,749.00
2,095,132.00
412,093.70
Issuance/Reduction of Debt, Net
1,675,209.90
2,641,321.30
4,107,212.70
953,217.00
4,441,986.20
Net Financing Cash Flow
1,715,209.90
3,385,541.60
9,097,211.80
841,156.70
8,030,541.20
Net Change in Cash
2,151,200.70
3,436,839.50
1,109,365.60
3,578,757.30
5,176,198.20
Free Cash Flow
1,979,671.70
2,358,673.60
3,413,042.70
2,568,916.50
3,282,785.80
Other Sources
589,170.60
1,844,000.00
4,131,312.00
2,529,236.50
4,216,967.50
Change in Capital Stock
-
790,020.30
4,989,999.10
1,794,373.70
3,588,555.10
Exchange Rate Effect
431.60
2,851.80
3,808.50
-
4,100.00
Other Uses
51,981.50
1,861,100.00
8,205,062.60
1,679,065.90
3,956,470.00

About PharmswellBio Co.

View Profile
Address
High Heels Building
Seoul SL 08514
Korea, Republic Of
Employees -
Website -
Updated 09/14/2018
PharmswellBio Co., Ltd. engages in the development, manufacture, and distribution of pharmaceutical raw materials. It operates through following business divisions: Active Pharmaceutical Ingredient and Other. Its products include synthesis material drugs, healthcare foods, and bio-pharmaceuticals.